期刊文献+

抗核抗体谱与结缔组织疾病相关间质性肺病的研究进展

Research Progress of Antinuclear Antibody Profile and Connective Tissue Dis-ease-Related Interstitial Lung Disease
下载PDF
导出
摘要 本文主要介绍了抗核抗体谱与CTD-ILD的研究现状和未来展望。近年来,CTD-ILD在人群中的患病率较以往有所上升,严重影响了CTD患者的生活质量,往往预后不良,甚至危及生命。本文就患者抗核抗体谱与CTD-ILD之间的联系做一探讨及总结,包括各种CTD与抗核抗体谱以及抗核抗体谱与结缔组织疾病相关间质性肺病的关系进行梳理,整理出危险因素,进而肺间质损害进行早期筛查和干预,极大可能可以改善SLE-ILD患者的预后。 This article mainly introduces the research status and future prospects of antinuclear antibody pro-file and CTD-ILD. In recent years, the prevalence of CTD-ILD in the population has increased com-pared with the past, which has seriously affected the quality of life of CTD patients, often with poor prognosis and even life-threatening. This article discusses and summarizes the relationship be-tween antinuclear antibody profile and CTD-ILD in patients, including the relationship between various CTDs and antinuclear antibody profile, and antinuclear antibody profile and connective tis-sue disease-related interstitial lung disease, and sorts out the risk factors, and then conducts early screening and intervention of lung interstitial damage, which is likely to improve the prognosis of patients with SLE-ILD.
作者 王娟 刘晖
出处 《临床医学进展》 2023年第10期16779-16785,共7页 Advances in Clinical Medicine
  • 相关文献

参考文献10

二级参考文献59

  • 1郭敏骅,屠文震.系统性硬皮病抗U_1RNP抗体的检测及其临床意义[J].临床皮肤科杂志,2005,34(12):812-813. 被引量:3
  • 2Gabrielli A, Awedimento EV, Krieg T. Scleroderma. N Engl J Med, 2009, 360:1989-2003.
  • 3Meyer OC, Fertig N, Lucas M, et al. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol, 2007, 34: 104-109.
  • 4Walker UA, Tyndall A, Czirjok L, et al. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Ann Rheum Dis, 2009, 68:856-862.
  • 5Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum, 1980, 23:581-590.
  • 6Clements P, Lachenbruch P, Seibold J, et al. Inter- and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol, 1995, 22:1281-1285.
  • 7Koenig M, Dieude M, Senecal JL. Predictive value of antinuelear autoantibodies: The lessons of the systemic sclerosis autoantibodies. Autoimmun Rev, 2008,7:588-593.
  • 8Santiago M, Baron M, Hudson M, et al. Antibodies to RNA polymerase Ⅲ in systemic sclerosis detected by ELISA. J Rheumatol, 2007, 34:1528-1534.
  • 9Cavazzana I, Angela C, Paolo A, et al. Anti-RNA polymerase Ⅲ antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression. Autoimmun Rev, 2009, 8:580-584.
  • 10詹克勤,吴杰敏,洪志海.弥漫型硬皮病抗DNA拓扑异构酶I抗体的检测及临床意义[J].实验与检验医学,2008,26(6):615-616. 被引量:1

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部